Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000667

Drug Information
Synonyms125-40-6; Butrate; Unicelles; 5-SEC-BUTYL-5-ETHYL-BARBITURIC ACID; NSC 27517; BRN 0199734; 5-Ethyl-5-isobutylbarbituric acid; 1135-61-1; Secbutabarbital [INN]; LS-23930; NSC27517; BRN 0199127; 97164-73-3; Sodium butabarbital; 5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione; Secbutabarbitalum; Butisol sodium; Butabarbital [USAN]; CHEBI:3228; Butabarbital (VAN); HSDB 3018; Secbutabarbitalum [INN-Latin]; Butatal; Butabarbital (USP); sec-Butobarbitone; 5-Ethyl-5-(1-methylpropyl)barbituric acid; 5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione; 5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione; Butatab; Nilox; Secbutabarbital; EINECS 204-738-6; MolPort-004-285-873; AC-16078; 5-Ethyl-5-(1-methylpropyl)barbiturate; D03180; 5-(butan-2-yl)-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione; UNII-P0078O25A9; Butabarb; Sarisol; Butabarbitone; Buticaps; Medarsed; WLN: T6VMVMV FHJ FY2 & 1 F2; Barbituric acid, 5-ethyl-5-isobutyl-; 5-sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione; CHEMBL449; Secbutobarbital; Secbutobarbitone; C07827; Barbituric acid, 5-sec-butyl-5-ethyl-; CID2479; LS-24330; butabarbital; AC1L1DRT; DB00237; 5-sec-Butyl-5-ethylmalonyl urea; 5-ethyl-5-(1-methylpropyl)pyrimidine-2,4,6(1H,3H,5H)-trione; 5-sec-Butyl-5-ethylbarbituric acid; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-; Secbutabarbitale [DCIT]; Butalan; Secbubarbital; Butisol; Secbutabarbitale
Trade NameButisol
[ICD9: 307.41, 307.42, 327.0, 780.51, 780.52   ICD10: F51.0, G47.0]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCCC(C)C1(C(=O)NC(=O)NC1=O)CC    
Therapeutic ClassAnti-anxiety Agents
CAS NumberCAS 125-40-6
PubChem Compound IDCID 2479.
PubChem Substance IDSID 10029.
TargetGamma-aminobutyric acid receptor subunit alpha-1Antagonist[2][3][4]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 085550 To Reference
Ref 2DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6. Epub 2007 Nov 29. To Reference
Ref 3Hypnotic drugs. Med Lett Drugs Ther. 2000 Aug 7;42(1084):71-2. To Reference
Ref 4Effect of barbiturates on polyphosphoinositide biosynthesis and protein kinase C activity in synaptosomes. Neuropharmacology. 1989 Dec;28(12):1317-23. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543